[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Swine Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

January 2018 | 190 pages | ID: S6C391BD564EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Swine Vaccines Market: By Vaccine Type (Inactivated Vaccines, Recombinant vaccines, Live attenuated vaccines, DNA vaccines, Subunit vaccines, Others), By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Market Outline: Swine Vaccines Market

Vaccines are the biological preparations that provide acquired immunity to the particular disease. Vaccine typically contains the agent that resembles a disease-causing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy.

Market Dynamics: Swine Vaccines Market

Drivers
Increase in the demand for healthy pork meat and rise in pork meat production
Rise in R&D expenditure for the innovation of newer vaccines
Rise in prevalence of various infectious diseases
Restraints
Stringent regulatory policies for the swine vaccine approval
Adverse effects such as allergies associated with the vaccines
High cost and lack of awareness about swine vaccines in underdeveloped countries

Market Scope: Swine Vaccines Market

Global swine vaccines market is segmented on the basis of vaccine type, disease type, distribution channel, and region

Based on the vaccine type, swine vaccines market is segmented into the following

Inactivated Vaccines
Recombinant vaccines
Live attenuated vaccines
DNA vaccines
Subunit vaccines
Others

Based on the disease type, swine vaccines market is segmented into the following

Viral Infections
Bacterial Infections
Parasitic Infection
Fungal Infections
Others

Based on the distribution channel, swine vaccines market is segmented into the following:

Veterinary Hospitals
Veterinary Pharmacies
Online Pharmacies

Based on the region, swine vaccines market is segmented into the following:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Competition Assessment: Swine Vaccines Market

Some of the players in the global swine vaccines market include:
Zoetis (Pfizer, Inc.) (U.S.)
Merck & Co. Inc. (U.S)
Virbac S.A. (France)
Boehringer Ingelheim Vetmedica (Germany)
Elanco (U.S.)
Bayer Animal Health (Germany)
Ceva Sante Animale (France)

Notable Market Developments: Swine Vaccines Market

In June 2016, Bayer Animal Health launched Bayovac Suishot APM-7 vaccine used against the respiratory diseases caused by A.pleuropneumoniae (serotype 2 and 5) and Pasteurella multocida (type A and D) in swine

Key Features of the Report:

The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

The report tracks recent innovations, key developments and startup’s details that are actively working in the market

The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1. EXECUTIVE SUMMARY

2. GLOBAL SWINE VACCINE MARKET INTRODUCTION

2.1. Global Swine Vaccine Market – Taxonomy
2.2. Global Swine Vaccine Market –Definitions
  2.2.1. Vaccine Type
  2.2.2. Disease Type

3. GLOBAL SWINE VACCINE MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Swine Vaccine Market Dynamic Factors - Impact Analysis
3.6. Global Swine Vaccine Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe

4. GLOBAL SWINE VACCINE MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis

5. GLOBAL SWINE VACCINE MARKET, BY VACCINE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

5.1. Inactivated Vaccines
  5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Recombinant vaccines
  5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Live Attenuated vaccines
  5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. DNA vaccines
  5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Subunit vaccines
  5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Others
  5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis

6. GLOBAL SWINE VACCINE MARKET FORECAST, BY DISEASE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023

6.1. Viral Infections
  6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Bacterial Infections
  6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Parasitic Infection
  6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Parasitic Infection
  6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Others
  6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis

7. GLOBAL SWINE VACCINE MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 – 2023

7.1. Veterinary Hospitals
  7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Veterinary Pharmacies
  7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Online Pharmacies
  7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL SWINE VACCINE MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

8.1. North America
  8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Swine Vaccine Market - Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Region, 2017 – 2023

9. NORTH AMERICA SWINE VACCINE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

9.1. Vaccine Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Inactivated Vaccines
  9.1.2. Recombinant vaccines
  9.1.3. Live attenuated vaccines
  9.1.4. DNA vaccines
  9.1.5. Subunit vaccines
  9.1.6. Others
9.2. Disease Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.2.1. Viral Infections
  9.2.2. Bacterial Infections
  9.2.3. Parasitic Infection
  9.2.4. Fungal Infections
  9.2.5. Others
9.3. Distribution Channel Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Veterinary Hospital
  9.3.2. Veterinaty Pharmacies
  9.3.3. Online Pharmaceis
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.4.1. U.S.
  9.4.2. Canada
9.5. North America Swine Vaccine Market - Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2017 – 2023
9.6. North America Swine Vaccine Market Dynamics – Trends

10. EUROPE SWINE VACCINE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

10.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.1.1. Germany
  10.1.2. UK
  10.1.3. France
  10.1.4. Spain
  10.1.5. Italy
  10.1.6. Russia
  10.1.7. Poland
  10.1.8. Rest of Europe
10.2. Europe Swine Vaccine Market - Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2017 – 2023
10.3. Europe Swine Vaccine Market Dynamics – Trends

11. ASIA-PACIFIC SWINE VACCINE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

11.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  11.1.1. Japan
  11.1.2. China
  11.1.3. India
  11.1.4. ASEAN
  11.1.5. Australia & New Zealand
  11.1.6. Rest of Asia-Pacific
11.2. Asia-Pacific Swine Vaccine Market - Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2017 – 2023
11.3. Asia-Pacific Swine Vaccine Market Dynamics – Trends

12. LATIN AMERICA SWINE VACCINE MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

12.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  12.1.1. Brazil
  12.1.2. Mexico
  12.1.3. Argentina
  12.1.4. Venezuela
  12.1.5. Rest of Latin America
12.2. Latin America Swine Vaccine Market - Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2017 – 2023
12.3. Latin America Swine Vaccine Market Dynamics – Trends

13. MIDDLE EAST AND AFRICA SWINE VACCINE MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

13.1. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  13.1.1. Gulf Cooperation Council (GCC) Countries
  13.1.2. Israel
  13.1.3. South Africa
  13.1.4. Rest of MEA
13.2. MEA Swine Vaccine Market - Opportunity Analysis Index, By Vaccine Type, By Disease Type, By Distribution Channel, and Country, 2017 – 2023
13.3. MEA Swine Vaccine Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. Zoetis (Pfizer, Inc.) (U.S.)
  14.2.2. Merck & Co. Inc. (U.S)
  14.2.3. Virbac S.A. (France)
  14.2.4. Boehringer Ingelheim Vetmedica (Germany)
  14.2.5. Elanco (U.S.)
  14.2.6. Bayer Animal Health (Germany)
  14.2.7. Ceva Sante Animale (France)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS


More Publications